Based in Melbourne, our researcher works day in and day out towards finding new treatments that will delay or
halt the disease.
Understanding the complexity of Niemann-Pick Type C Disease is a task in itself. Our recent research has shown that carriers of NPC causing mutations (i.e. parents) are at risk of developing delayed NPC Disease.